Published in Physiol Behav on January 01, 1988
Reduced nicotine reward in obesity: cross-comparison in human and mouse. Psychopharmacology (Berl) (2005) 1.05
Direct inhibition of arcuate proopiomelanocortin neurons: a potential mechanism for the orexigenic actions of dynorphin. J Physiol (2013) 0.92
Changes in mouse mu opioid receptor Exon 7/8-like immunoreactivity following food restriction and food deprivation in rats. Synapse (2009) 0.76
Central non-opioid physiological and pathophysiological effects of dynorphin A and related peptides. J Psychiatry Neurosci (1992) 0.76
Pain intensity processing within the human brain: a bilateral, distributed mechanism. J Neurophysiol (1999) 3.27
BIOTIN (BIOS IIB, VITAMIN H)--AN ESSENTIAL GROWTH FACTOR FOR CERTAIN STAPHYLOCOCCI. Science (1940) 3.12
Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron (1994) 2.61
Analysis of the native quaternary structure of vanilloid receptor 1. J Biol Chem (2001) 2.55
A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates. J Infect Dis (1975) 2.14
Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. Proc Natl Acad Sci U S A (1991) 2.04
Recombinant proteins attached to a nickel-NTA column: use in affinity purification of antibodies. Biotechniques (1994) 1.62
Genetic predictors for acute experimental cold and heat pain sensitivity in humans. J Med Genet (2006) 1.62
Substantia nigra: site of anticonvulsant activity mediated by gamma-aminobutyric acid. Science (1982) 1.60
Ligand-induced dynamic membrane changes and cell deletion conferred by vanilloid receptor 1. J Biol Chem (2000) 1.59
Severity of disease and risk of malignant change in hereditary multiple exostoses. A genotype-phenotype study. J Bone Joint Surg Br (2004) 1.57
Genomic integration and gene expression by a modified adenoviral vector. Nat Biotechnol (2000) 1.55
Utilization of Nicotinic Acid and Related Pyridine Compounds by the Proteus Group of Organisms. J Bacteriol (1940) 1.55
Syndromic obesity and diabetes: changes in body composition with age and mutation analysis of ALMS1 in 12 United Kingdom kindreds with Alstrom syndrome. J Clin Endocrinol Metab (2006) 1.50
Computerized tomography cystography for the diagnosis of traumatic bladder rupture. J Urol (2000) 1.37
Hemispheric lateralization of somatosensory processing. J Neurophysiol (2001) 1.35
Excitatory amino acid recognition sites coupled with inositol phospholipid metabolism: developmental changes and interaction with alpha 1-adrenoceptors. Proc Natl Acad Sci U S A (1986) 1.34
Design of matching networks for low noise preamplifiers. Magn Reson Med (1995) 1.30
Coupling of inositol phospholipid metabolism with excitatory amino acid recognition sites in rat hippocampus. J Neurochem (1986) 1.26
Anandamide activates vanilloid receptor 1 (VR1) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing VR1. J Biol Chem (2001) 1.26
Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum. Eur J Neurosci (1996) 1.20
In situ hybridization histochemistry and immunocytochemistry reveal an increase in spinal dynorphin biosynthesis in a rat model of peripheral inflammation and hyperalgesia. Proc Natl Acad Sci U S A (1988) 1.14
A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain. Hum Gene Ther (1999) 1.13
Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms. Eur J Pharmacol (1991) 1.09
Cloning of a DNA binding protein that is a tyrosine kinase substrate and recognizes an upstream initiator-like sequence in the promoter of the preprodynorphin gene. Brain Res Mol Brain Res (1994) 1.07
Rat brain protein kinase C: purification, antibody production, and quantification in discrete regions of hippocampus. J Neurochem (1989) 1.05
Monocyte chemoattractant protein-1 in the choroid plexus: a potential link between vascular pro-inflammatory mediators and the CNS during peripheral tissue inflammation. Neuroscience (2008) 1.05
Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Brain Res Mol Brain Res (1989) 1.04
Dynorphin expression and Fos-like immunoreactivity following inflammation induced hyperalgesia are colocalized in spinal cord neurons. Brain Res Mol Brain Res (1991) 1.04
Dynorphin increases in the dorsal spinal cord in rats with a painful peripheral neuropathy. Peptides (1990) 1.02
Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation. Brain Res (1991) 1.00
Fos-like proteins in the lumbosacral spinal cord following noxious and non-noxious colorectal distention in the rat. Pain (1992) 0.99
Salivary anti-Ro60 and anti-Ro52 antibody profiles to diagnose Sjogren's Syndrome. J Dent Res (2011) 0.98
The actions of exogenous dehydroepiandrosterone in experimental animals and humans. Proc Soc Exp Biol Med (1998) 0.97
Stress selectively increases fos protein in dopamine neurons innervating the prefrontal cortex. Cereb Cortex (1992) 0.97
Transcription factor regulation of prodynorphin gene expression following rat hindpaw inflammation. Brain Res Mol Brain Res (1998) 0.96
Patterns of epithelial expression of Fos protein suggest important role in the transition from viable to cornified cell during keratinization. Development (1991) 0.93
Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action. Mol Cell Neurosci (1992) 0.93
Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor. Clin Exp Metastasis (1997) 0.92
Psychosocial effect of vitiligo: a comparison of vitiligo patients with "normal" control subjects, with psoriasis patients, and with patients with other pigmentary disorders. J Am Acad Dermatol (1986) 0.92
Antony van Leeuwenhoek: tercentenary of his discovery of bacteria. Bacteriol Rev (1976) 0.92
Adenoviral gene transfer to spinal-cord neurons: intrathecal vs. intraparenchymal administration. Brain Res (1998) 0.90
Polyacetylene carboxylic acids from Mitrephora celebica. J Nat Prod (2001) 0.89
Effects of D2 dopamine receptor antagonists on Fos protein expression in the striatal complex and entorhinal cortex of the nonhuman primate. Synapse (1996) 0.89
Antimicrobial diterpenes from the stem bark of Mitrephora celebica. Fitoterapia (2002) 0.89
Changes in dynorphin, enkephalin and cholecystokinin content of hippocampus and substantia nigra after amygdala kindling. Brain Res (1986) 0.89
UREB1, a tyrosine phosphorylated nuclear protein, inhibits p53 transactivation. Oncogene (1995) 0.88
Actions of intrathecal diphtheria toxin-substance P fusion protein on models of persistent pain. Pain (1999) 0.88
Cellular compartments of GABA in brain and their relationship to anticonvulsant activity. Mol Cell Biochem (1981) 0.88
Current experience with computed tomographic cystography and blunt trauma. World J Surg (2001) 0.88
Epidural resiniferatoxin induced prolonged regional analgesia to pain. Brain Res (1999) 0.87
Seizure protection and increased nerve-terminal GABA: delayed effects of GABA transaminase inhibition. Science (1980) 0.87
Basal and inducible transcriptional activity of an upstream AP-1/CRE element (DYNCRE3) in the prodynorphin promoter. Mol Cell Neurosci (1994) 0.86
Peripheral inflammation is associated with increased dynorphin immunoreactivity in both projection and local circuit neurons in the superficial dorsal horn of the rat lumbar spinal cord. Neurosci Lett (1989) 0.86
Fos-like immunoreactivity increases in the lumbar spinal cord following a chronic constriction injury to the sciatic nerve of rat. Neurosci Lett (1996) 0.85
c-Fos expression in NMDA receptor-contained neurons in spinal cord in a rat model of inflammation: a double immunocytochemical study. Brain Res (1998) 0.85
Nociception and opioid-induced analgesia in lean (Fa/-) and obese (fa/fa) Zucker rats. Physiol Behav (1986) 0.85
Differential induction of Fos protein and a Fos-related antigen following acute and repeated cocaine administration. Brain Res Mol Brain Res (1994) 0.85
Rapid plasmid DNA sequencing with multiple octamer primers. Biotechniques (1994) 0.84
Immunohistochemical localization of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor subunits in the substantia nigra pars compacta of the rat. Neuroscience (1999) 0.84
The beta-subunit of human chorionic gonadotrophin exists as a homodimer. J Mol Endocrinol (1999) 0.84
Pressor responses to ephedrine are not impaired in dopamine beta-hydroxylase knockout mice. Br J Pharmacol (2006) 0.83
Braking the accelerator hypothesis? Diabetologia (2003) 0.83
Spinal cord genes enriched in rat dorsal horn and induced by noxious stimulation identified by subtraction cloning and differential hybridization. Neuroscience (2001) 0.83
Dehydroepiandrosterone: antiglucocorticoid action in mice. Am J Med Sci (1992) 0.83
CDP840. A prototype of a novel class of orally active anti-inflammatory phosphodiesterase 4 inhibitors. Bioorg Med Chem Lett (2002) 0.83
Co-localization of N-methyl-D-aspartate receptors and substance P (neurokinin-1) receptors in rat spinal cord. Neurosci Lett (2000) 0.82
Effect of multiple dorsal rhizotomies on calcitonin gene-related peptide-like immunoreactivity in the lumbosacral dorsal spinal cord of the cat: a radioimmunoassay analysis. Peptides (1990) 0.82
Intrathecally administered cholera toxin blocks allodynia and hyperalgesia in persistent pain models. J Pain (2001) 0.82
New technologies for studying the complexity of oral diseases. Oral Dis (2011) 0.82
GR89,696 is a kappa-2 opioid receptor agonist and a kappa-1 opioid receptor antagonist in the guinea pig hippocampus. J Pharmacol Exp Ther (1997) 0.82
Spinal kappa1 and kappa2 opioid binding sites in rats, guinea pigs, monkeys and humans. Neuroreport (1998) 0.82
Electrical stimulation of visceral afferent pathways in the pelvic nerve increases c-fos in the rat lumbosacral spinal cord. Neurosci Lett (1991) 0.82
An isobolographic analysis of the effects of N-methyl-D-aspartate and NK1 tachykinin receptor antagonists on inflammatory hyperalgesia in the rat. Br J Pharmacol (1996) 0.81
Global cerebral blood flow decreases during pain. J Cereb Blood Flow Metab (1998) 0.81
Stimulation of adrenal medullary cells in vivo and in vitro induces expression of c-fos proto-oncogene. Oncogene (1990) 0.81
NMDAR1 glutamate receptor subunit isoforms in neostriatal, neocortical, and hippocampal nitric oxide synthase neurons. J Neurosci (1998) 0.81
Challenges to Editors of Scientific Journals. Science (1963) 0.81
Analgesic activity and release of [MET5]enkephalin-Arg6-Gly7-Leu8 from rat spinal cord in vivo. Eur J Pharmacol (1986) 0.80
Localization of alternatively spliced NMDAR1 glutamate receptor isoforms in rat striatal neurons. J Comp Neurol (1999) 0.80
A kinetic analysis of substance P trafficking. J Pharm Sci (2003) 0.80
An automated measurement system for characterization of RF and gradient coil parameters. J Magn Reson Imaging (1998) 0.80
Substance P antagonists in substantia nigra are anticonvulsant. Brain Res (1986) 0.79
Chronic tooth pulp inflammation causes transient and persistent expression of Fos in dynorphin-rich regions of rat brainstem. Brain Res (2000) 0.79
Dehydroepiandrosterone alters lipid profiles in Zucker rats. Lipids (2000) 0.79
Antiglucocorticoid action of dehydroepiandrosterone in young obese Zucker rats. Int J Obes Relat Metab Disord (1992) 0.79
Effects of MDMA administration on scopolamine-induced disruptions of learning and performance in rats. Pharmacol Biochem Behav (2004) 0.79
Agostino Bassi bicentennial (1773-1973). Bacteriol Rev (1973) 0.79
Changes in the dynamic state of brain proenkephalin-derived peptides during amygdaloid kindling. J Neurosci Res (1986) 0.79
Transcriptional regulation of the rat prodynorphin gene. NIDA Res Monogr (1991) 0.78
GABAergic denervation of rat substantia nigra: functional and pharmacological properties. Brain Res (1980) 0.78
Abnormality of alpha 1-adrenergic receptors in the frontal cortex of epileptic rats. J Neurochem (1986) 0.78
The effect of cholecystokinin octapeptide on pituitary-adrenal hormone secretion. Regul Pept (1981) 0.78
Influence of cholecystokinin on hypothalamic-stalk median-eminence-extract stimulation of ACTH output from isolated pituitary cells. Life Sci (1982) 0.78
In vivo control of NMDA receptor transcript level in motoneurons by viral transduction of a short antisense gene. Brain Res Mol Brain Res (2001) 0.78
MR flow measurement using RF phase gradients in receiver coil arrays. IEEE Trans Biomed Eng (1993) 0.78
URE, an initiator (Inr)-like site, suppresses the promoter of the rat dynorphin gene. Biochem Biophys Res Commun (1997) 0.78
Distribution of Met5-enkephalin-Arg6, Phe7 in rat spinal cord. Brain Res (1983) 0.78